Company News

Share this article:
IMS Health launched Ask IMS, a web-based service offering low-cost, entry level strategic market intelligence to newer biopharma firms and startups. The offering, says IMS, provides country specific data on sales and prescribing trends, primary disease treatments and promotion activities in specific markets.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.